F. Pons, M. Varela, and J. M. Llovet, Staging systems in hepatocellular carcinoma, HPB (Oxford), vol.7, pp.35-41, 2005.

J. M. Llovet, S. Ricci, and V. Mazzaferro, Sorafenib in advanced hepatocellular carcinoma, N Engl J Med, vol.359, pp.378-390, 2008.

E. , clinical practice guidelines: management of hepatocellular carcinoma, J Hepatol, vol.56, pp.908-943, 2012.

R. Yamada, M. Sato, and M. Kawabata, Hepatic artery embolization in 120 patients with unresectable hepatoma, Radiology, vol.148, pp.397-401, 1983.

C. Breedis and G. Young, The blood supply of neoplasms in the liver, Am J Pathol, vol.30, pp.969-977, 1954.

J. M. Llovet, M. I. Real, and X. Montana, Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, Lancet, vol.359, pp.1734-1739, 2002.

J. Bruix, J. M. Llovet, and A. Castells, Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution, Hepatology, vol.27, pp.1578-1583, 1998.

J. M. Llovet and J. Bruix, Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival, Hepatology, vol.37, pp.429-442, 2003.

L. Marelli, R. Stigliano, and C. Triantos, Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies, Cardiovasc Intervent Radiol, vol.30, pp.6-25, 2007.

P. E. Majno, R. Adam, and H. Bismuth, Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis, Ann Surg, vol.226, pp.688-701, 1997.

W. C. Chapman, M. Doyle, M. B. Stuart, and J. E. , Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation, Ann Surg, vol.248, pp.617-625, 2008.

F. Y. Yao, R. K. Kerlan, J. Hirose, and R. , Excellent outcome following downstaging of hepatocellular carcinoma prior to liver transplantation: an intention-totreat analysis, Hepatology, vol.48, pp.819-827, 2008.

Z. Kan, Dynamic study of iodized oil in the liver and blood supply to hepatic tumors. An experimental investigation in several animal species, Acta Radiol Suppl, vol.408, pp.1-25, 1996.

N. Terayama, O. Matsui, and T. Gabata, Accumulation of iodized oil within the nonneoplastic liver adjacent to hepatocellular carcinoma via the drainage routes of the tumor after transcatheter arterial embolization, Cardiovasc Intervent Radiol, vol.24, pp.383-387, 2001.

T. De-baere, D. A. Briquet, and R. , Modification of arterial and portal hemodynamics after injection of iodized oils and different emulsions of iodized oils in the hepatic artery: an experimental study, J Vasc Interv Radiol, vol.9, pp.305-310, 1998.

K. Takayasu, S. Arii, and N. Matsuo, Comparison of CT findings with resected specimens after chemoembolization with iodized oil for hepatocellular carcinoma, AJR Am J Roentgenol, vol.175, pp.699-704, 2000.

S. El-khaddari, J. L. Gaudin, and H. Abidi, Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session

, Gastroenterol Clin Biol, vol.26, pp.728-734, 2002.

D. Y. Kim, H. J. Ryu, and J. Y. Choi, Radiological response predicts survival following transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma, Aliment Pharmacol Ther, vol.35, pp.1343-1350, 2012.

R. C. Gaba, S. Baumgarten, and B. O. Omene, Ethiodized oil uptake does not predict doxorubicin drug delivery after chemoembolization in VX2 liver tumors, J Vasc Interv Radiol, vol.23, pp.265-273, 2012.

T. Masada, T. Tanaka, and H. Nishiofuku, Techniques to Form a Suitable Lipiodol-Epirubicin Emulsion by Using 3-Way Stopcock Methods in Transarterial Chemoembolization for Liver Tumor, J Vasc Interv Radiol, 2017.

K. Hong, A. Khwaja, and E. Liapi, New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer, Clin Cancer Res, vol.12, pp.2563-2567, 2006.

J. Kettenbach, A. Stadler, and I. V. Katzler, Drug-loaded microspheres for the treatment of liver cancer: review of current results, Cardiovasc Intervent Radiol, vol.31, pp.468-476, 2008.

O. Jordan, A. Denys, and T. De-baere, Comparative study of chemoembolization loadable beads: in vitro drug release and physical properties of DC bead and hepasphere loaded with doxorubicin and irinotecan, J Vasc Interv Radiol, vol.21, pp.1084-1090, 2010.

S. Becker, N. Lepareur, and V. Cadeillan, Optimization of hepatocarcinoma uptake with radiolabeled lipiodol: development of new lipiodol formulations with increased viscosity, Cancer Biother Radiopharm, vol.27, pp.149-155, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00867018

T. De-baere, J. Dufaux, and A. Roche, Circulatory alterations induced by intraarterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study, Radiology, vol.194, pp.165-170, 1995.

T. De-baere, X. Zhang, and A. B. , Quantification of tumor uptake of iodized oils and emulsions of iodized oils: experimental study, Radiology, vol.201, pp.731-735, 1996.

H. Demachi, O. Matsui, H. Abo, and H. Tatsu, Simulation model based on nonnewtonian fluid mechanics applied to the evaluation of the embolic effect of emulsions of iodized oil and anticancer drug, Cardiovasc Intervent Radiol, vol.23, pp.285-290, 2000.

S. Baumgarten, R. C. Gaba, and R. B. Van-breemen, Confirmation of drug delivery after liver chemoembolization: direct tissue doxorubicin measurement by UHPLCMS-MS, Biomed Chromatogr, vol.26, pp.1529-1533, 2012.

T. De-baere, Y. Arai, and R. Lencioni, Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion, Cardiovasc Intervent Radiol, 2015.

R. Lencioni, T. De-baere, and M. C. Soulen, Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data, Hepatology, vol.64, pp.106-116, 2016.

S. Miyayama, O. Matsui, and M. Yamashiro, Ultraselective transcatheter arterial chemoembolization with a 2-f tip microcatheter for small hepatocellular carcinomas: relationship between local tumor recurrence and visualization of the portal vein with iodized oil, J Vasc Interv Radiol, vol.18, pp.365-376, 2007.

A. Bouvier, V. Ozenne, and A. C. , Transarterial chemoembolisation: effect of selectivity on tolerance, tumour response and survival, Eur Radiol, vol.21, pp.1719-1726, 2011.

I. J. Lee, J. W. Chung, and Y. H. Yin,

, Hepatic Arteriography in Chemoembolization for Hepatocellular Carcinoma: Performance Depicting Tumors and Tumor Feeders, Cardiovasc Intervent Radiol, vol.38, pp.1218-1230, 2015.

M. Ronot, M. Abdel-rehim, and A. Hakime, Cone-Beam CT Angiography for Determination of Tumor-Feeding Vessels During Chemoembolization of Liver Tumors: Comparison of Conventional and Dedicated-Software Analysis, J Vasc Interv Radiol, 2015.

J. W. Choi, H. J. Cho, and J. H. Park, Comparison of drug release and pharmacokinetics after transarterial chemoembolization using diverse lipiodol emulsions and drug-eluting beads, PLoS One, vol.9, p.115898, 2014.

L. Mondazzi, R. Bottelli, and G. Brambilla, Transarterial oily chemoembolization for the treatment of hepatocellular carcinoma: a multivariate analysis of prognostic factors, Hepatology, vol.19, pp.1115-1123, 1994.

T. J. Vogl, M. Trapp, and H. Schroeder, Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center, Radiology, vol.214, pp.349-357, 2000.

Z. Wang, R. Chen, and R. Duran, Intraprocedural 3D Quantification of Lipiodol Deposition on Cone-Beam CT Predicts Tumor Response After Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma, Cardiovasc Intervent Radiol, vol.38, pp.1548-1556, 2015.

X. Yin, Y. Guo, and W. Li, Chemical shift MR imaging methods for the quantification of transcatheter lipiodol delivery to the liver: preclinical feasibility studies in a rodent model, Radiology, vol.263, pp.714-722, 2012.

M. Boulin, A. Schmitt, and E. Delhom, Improved stability of lipiodol-drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin, Eur Radiol, vol.26, pp.601-609, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01436674

F. Deschamps, G. Farouil, and W. Gonzalez, Stabilization Improves Theranostic Properties of Lipiodol(R)-Based Emulsion During Liver Trans-arterial Chemo-embolization in a VX2 Rabbit Model, Cardiovasc Intervent Radiol, vol.40, pp.907-913, 2017.

F. Jahanzad, M. A. Jd, and S. Sajjadi, Dynamics of Transitional Phase Inversion Emulsification: Effect of Addition Time on the Type of Inversion and Drop Size, Ind. Eng. Chem. Res, vol.49, pp.7631-7637, 2019.

J. M. Idee and B. Guiu, Use of Lipiodol as a drug-delivery system for transcatheter arterial chemoembolization of hepatocellular carcinoma: a review, Crit Rev Oncol Hematol, vol.88, pp.530-549, 2013.

. Ramsden, Separation of Solids in the Surface-layers of Solutions and 'Suspension' (Observations on surface-membranes, Bubbles, Emulsions, and Mechanical Cooagulation). Prliminary Account, Proc. R. Soc. Lond, vol.72, pp.156-164, 1903.

E. C. Pickering and . Emulsion, J Chem Soc, p.91, 1907.

Y. Chevalier, Emulsions stabilized with solid nanoparticles: Pickering emulsions
URL : https://hal.archives-ouvertes.fr/hal-02044597

, Coll. Surf. A, vol.439, pp.23-34, 2013.

C. P. Whitby, L. H. Lim, and N. G. Eskandar, Poly(lactic-co-glycolic acid) as a particulate emulsifier, J Colloid Interface Sci, vol.375, pp.142-147, 2012.

L. A. Guzman, . Lv, C. Song, Y. Jang, A. M. Lincoff et al., Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty, Circulation, vol.94, pp.1441-1448, 1996.

C. E. Astete and . Sc, Synthesis and characterization of PLGA nanoparticles, J Biomater Sci Polym Ed, vol.17, pp.247-289, 2006.

I. Bala, . Hs, and M. N. Kumar, PLGA nanoparticles in drug delivery: the state of the art, Crit Rev Ther Drug Carrier Syst, vol.21, pp.387-422, 2004.

B. P. Binks, P. D. Fletcher, and B. L. Holt, Phase inversion of particle-stabilised perfume oil-water emulsions: experiment and theory, Phys Chem Chem Phys, vol.12, pp.11954-11966, 2010.

I. Okayasu, S. Hatakeyama, and T. Yoshida, Selective and persistent deposition and gradual drainage of iodized oil, Lipiodol in the hepatocellular carcinoma after injection into the feeding hepatic artery, Am J Clin Pathol, vol.90, pp.536-544, 1988.

F. Laredj-bourezg, . Cy, O. Boyron, and M. Bolzingera, Emulsions stabilized with organic solid particles, Coll. Surf. A, vol.413, pp.252-259, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02044599

F. Laredj-bourezg, J. Pelletier, M. Rovere, B. Smatti, and C. Y. ,

, Pickering Emulsions Stabilised by Biodegradable Particles Offer a Double Level of Controlled Delivery of Hydrophobic Drugs, Adv Dermatological Sci, vol.20, pp.143-156, 2014.

E. Lilienberg, I. R. Dubbelboer, and A. Karalli, In Vivo Drug Delivery Performance of Lipiodol-Based Emulsion or Drug-Eluting Beads in Patients with Hepatocellular Carcinoma, Mol Pharm, vol.14, pp.448-458, 2017.

V. Boige, D. Malka, and D. Elias, Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure, Ann Surg Oncol, vol.15, pp.219-226, 2008.
DOI : 10.1245/s10434-007-9581-7

F. Petrelli, A. Coinu, and K. Borgonovo, Oxaliplatin-based chemotherapy: a new option in advanced hepatocellular carcinoma. a systematic review and pooled analysis, Clin Oncol (R Coll Radiol), vol.26, pp.488-496, 2014.
DOI : 10.1016/j.clon.2014.04.031

M. Ducreux, M. Ychou, and A. Laplanche, Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer, J Clin Oncol, vol.23, pp.4881-4887, 2005.

J. H. Kim, H. K. Yoon, and K. B. Sung, Transcatheter arterial chemoembolization or chemoinfusion for unresectable intrahepatic cholangiocarcinoma: clinical efficacy and factors influencing outcomes, Cancer, vol.113, pp.1614-1622, 2008.

F. Deschamps, L. Moine, and T. Isoardo, Parameters for Stable Water-in-Oil Lipiodol Emulsion for Liver Trans-Arterial Chemo-Eembolization, Cardiovasc Intervent Radiol, 2017.

R. Dzodic, G. Gomez-abuin, and P. Rougier, Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: comparative results with cisplatin using a rabbit VX2 tumor model, Anticancer Drugs, vol.15, pp.647-650, 2004.

B. Sangro, C. Gomez-martin, and M. De-la-mata, A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C, J Hepatol, vol.59, pp.81-88, 2013.

A. B. El-khoueiry, B. Sangro, and T. Yau, Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial, Lancet, vol.389, pp.2492-2502, 2017.

A. Marabelle, H. Kohrt, C. Caux, and R. Levy, Intratumoral immunization: a new paradigm for cancer therapy, Clin Cancer Res, vol.20, pp.1747-1756, 2014.

M. F. Fransen, T. C. Van-der-sluis, and F. Ossendorp, Controlled local delivery of CTLA-4 blocking antibody induces CD8+ T-cell-dependent tumor eradication and decreases risk of toxic side effects, Clin Cancer Res, vol.19, pp.5381-5389, 2013.

A. Marabelle, H. Kohrt, and I. Sagiv-barfi, Depleting tumor-specific Tregs at a single site eradicates disseminated tumors, J Clin Invest, vol.123, pp.2447-2463, 2013.

J. M. Pitt, A. Marabelle, and A. Eggermont, Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy, Ann Oncol, vol.27, pp.1482-1492, 2016.

J. D. Wolchok, B. Neyns, and L. G. , Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study, Lancet Oncol, vol.11, pp.155-164, 2010.